Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | TSC2 |
Variant | A1141T |
Impact List | missense |
Protein Effect | unknown |
Gene Variant Descriptions | TSC2 A1141T does not lie within any known functional domains of the Tsc2 protein (UniProt.org). A1141T has been identified in sequencing studies (PMID: 25724664), but has not been biochemically characterized and therefore, its effect on Tsc2 protein function is unknown (PubMed, Oct 2024). |
Associated Drug Resistance | |
Category Variants Paths |
TSC2 mutant TSC2 A1141T |
Transcript | NM_000548.5 |
gDNA | chr16:g.2080188G>A |
cDNA | c.3421G>A |
Protein | p.A1141T |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
XM_011522640 | chr16:g.2080320G>A | c.3421G>A | p.A1141T | RefSeq | GRCh38/hg38 |
XM_005255531 | chr16:g.2080317G>A | c.3421G>A | p.A1141T | RefSeq | GRCh38/hg38 |
NM_001077183 | chr16:g.2080320G>A | c.3421G>A | p.A1141T | RefSeq | GRCh38/hg38 |
XM_011522639 | chr16:g.2080317G>A | c.3421G>A | p.A1141T | RefSeq | GRCh38/hg38 |
NM_001077183.2 | chr16:g.2080320G>A | c.3421G>A | p.A1141T | RefSeq | GRCh38/hg38 |
NM_001406665.1 | chr16:g.2080320G>A | c.3421G>A | p.A1141T | RefSeq | GRCh38/hg38 |
XM_011522639.3 | chr16:g.2080317G>A | c.3421G>A | p.A1141T | RefSeq | GRCh38/hg38 |
NM_001370405.1 | chr16:g.2080317G>A | c.3421G>A | p.A1141T | RefSeq | GRCh38/hg38 |
XM_011522636.2 | chr16:g.2080188G>A | c.3421G>A | p.A1141T | RefSeq | GRCh38/hg38 |
NM_000548.5 | chr16:g.2080188G>A | c.3421G>A | p.A1141T | RefSeq | GRCh38/hg38 |
XM_005255529.4 | chr16:g.2080317G>A | c.3421G>A | p.A1141T | RefSeq | GRCh38/hg38 |
NM_001114382.3 | chr16:g.2080188G>A | c.3421G>A | p.A1141T | RefSeq | GRCh38/hg38 |
XM_011522636 | chr16:g.2080188G>A | c.3421G>A | p.A1141T | RefSeq | GRCh38/hg38 |
NM_001363528.2 | chr16:g.2080317G>A | c.3421G>A | p.A1141T | RefSeq | GRCh38/hg38 |
NM_021055.3 | chr16:g.2080317G>A | c.3421G>A | p.A1141T | RefSeq | GRCh38/hg38 |
XM_005255531.4 | chr16:g.2080317G>A | c.3421G>A | p.A1141T | RefSeq | GRCh38/hg38 |
XM_017023616 | chr16:g.2080320G>A | c.3421G>A | p.A1141T | RefSeq | GRCh38/hg38 |
XM_011522636.3 | chr16:g.2080188G>A | c.3421G>A | p.A1141T | RefSeq | GRCh38/hg38 |
XM_011522640.2 | chr16:g.2080320G>A | c.3421G>A | p.A1141T | RefSeq | GRCh38/hg38 |
NM_001370404.1 | chr16:g.2080320G>A | c.3421G>A | p.A1141T | RefSeq | GRCh38/hg38 |
NM_000548.4 | chr16:g.2080188G>A | c.3421G>A | p.A1141T | RefSeq | GRCh38/hg38 |
NM_001114382.2 | chr16:g.2080188G>A | c.3421G>A | p.A1141T | RefSeq | GRCh38/hg38 |
NM_001114382 | chr16:g.2080188G>A | c.3421G>A | p.A1141T | RefSeq | GRCh38/hg38 |
NM_001077183.3 | chr16:g.2080320G>A | c.3421G>A | p.A1141T | RefSeq | GRCh38/hg38 |
NM_001406698.1 | chr16:g.2088290G>A | c.3421G>A | p.A1141T | RefSeq | GRCh38/hg38 |
NM_001406679.1 | chr16:g.2081684G>A | c.3421G>A | p.A1141T | RefSeq | GRCh38/hg38 |
XM_005255529 | chr16:g.2080317G>A | c.3421G>A | p.A1141T | RefSeq | GRCh38/hg38 |
NM_000548 | chr16:g.2080188G>A | c.3421G>A | p.A1141T | RefSeq | GRCh38/hg38 |
XM_017023616.1 | chr16:g.2080320G>A | c.3421G>A | p.A1141T | RefSeq | GRCh38/hg38 |
XM_024450413.1 | chr16:g.2080320G>A | c.3421G>A | p.A1141T | RefSeq | GRCh38/hg38 |
XM_011522639.2 | chr16:g.2080317G>A | c.3421G>A | p.A1141T | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|